Polyurethane Foam-Pink Pad (RCT) Use in OR
pink-pad
Effectiveness of Polyurethane Foam (Pink Pad) Compared With Mepilex Dressing for Pressure Ulcer Prevention in Operating Room: A Randomized Control Clinical Trial
2 other identifiers
interventional
100
1 country
1
Brief Summary
King Abdullah medical city has a cardiac center, and a lot of open-heart surgeries are performed there, and both polyurethane foam (pink Pad) and Mepilex dressing are applied to those patients. Therefore, the present study was designed to compare the effects of polyurethane foam (pink Pad) versus Mepilex dressing for prevention of pressure ulcer in operating room.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2023
CompletedFirst Submitted
Initial submission to the registry
November 25, 2024
CompletedFirst Posted
Study publicly available on registry
January 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2025
CompletedJanuary 24, 2025
January 1, 2025
2 years
November 25, 2024
January 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pressure ulcer incidence
Pressure ulcer incidence will be assessed by using Bates-Jensen Wound Assessment Tool (BWAT) after operation then day 3 and day 7 for both treatments.
7 days
Secondary Outcomes (1)
occurrence of pressure ulcer
7 days
Study Arms (2)
Polyurethane foams (Pink Pad)
ACTIVE COMPARATORa single use system for use in surgical procedures.it will be used only by operating room nurses Patient will be examined by wound management team after the operation then at day 3- and 7-days post operation.
Mepilex Border Sacrum dressings
ACTIVE COMPARATORa single use system for use in surgical procedures.it will be used only by operating room nurses Patient will be examined by wound management team after the operation then at day 3- and 7-days post operation.
Interventions
Both types of intervention will be available in the operating room. Patient will be examined by head nurse of wound management team after the operation then at day 3- and 7-days post operation. The dressing should be removed after 7 days post operation or if there is any clinical indication for removal. If a patient is discharged before 7 days post operation for any reason the head nurse of wound management team will examine the patient before discharge. Follow up will be for maximum 7 days post operation for each subject. Any patient will be unable to continue the study because of death or change in the care setting will be excluded from the study.
Both types of intervention will be available in the operating room. Patient will be examined by head nurse of wound management team after the operation then at day 3- and 7-days post operation. The dressing should be removed after 7 days post operation or if there is any clinical indication for removal. If a patient is discharged before 7 days post operation for any reason the head nurse of wound management team will examine the patient before discharge. Follow up will be for maximum 7 days post operation for each subject. Any patient will be unable to continue the study because of death or change in the care setting will be excluded from the study.
Eligibility Criteria
You may qualify if:
- Subjects ≥ 18.
- Willing to participate.
- Patients undergoing cardiac surgery.
- Patient who is at risk for PU development as measured with Braden scale.
- Patient who has skin intact and having a life expectancy greater than 72 hours as per clinical judgement.
You may not qualify if:
- Subjects under 17
- Not consenting to participate
- Patients with suspected hypersensitivity reactions to any of the dressing formulation's ingredients.
- Patients who are unable to continue the study because of death or change in the care setting.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Abdulla Medical City in Holy capital
Mecca, Western Reagan, 21955, Saudi Arabia
Related Publications (1)
Elhihi EA, Almuwallad SA, Alqrashi BM, Nada EM, Alduaiji NA, Alfakeeh AA. Effectiveness of a Single-Use Polyurethane Foam Positioning Pad Compared With Five-Layer Foam Sacral Dressing for Pressure Ulcer Prevention in the Operating Room: A Randomized Controlled Clinical Trial. Health Sci Rep. 2025 Aug 10;8(8):e70963. doi: 10.1002/hsr2.70963. eCollection 2025 Aug.
PMID: 40791282DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Wedian O. Almowallad / Head of Clinical Trial Department, Master
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nursing Research and Evidence Based Practice Department
Study Record Dates
First Submitted
November 25, 2024
First Posted
January 24, 2025
Study Start
October 10, 2023
Primary Completion
October 10, 2025
Study Completion
October 10, 2025
Last Updated
January 24, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
individual participant data (IPD) will not be shared , but the data can be reviewed by regulatory officer